Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > 700mg oat beta glucan chewey:
View:
Post by prophetoffactz on Feb 24, 2024 8:01pm

700mg oat beta glucan chewey:

Certainly! Let’s explore products with 700mg of oat beta glucan per serving and their potential health benefits, particularly their impact on LDL cholesterol. Additionally, we’ll discuss the competitive landscape.

  1. Nutrim Oat Beta Glucan:
  1. Competitiveness:
    • Ceapro’s Novel Nutraceutical Product, approved by Health Canada, seems promising. Its claims include LDL cholesterol reduction, support for cardiovascular health, and risk reduction for Type 2 diabetes.
    • However, Nutrim’s concentrated oat beta-glucan powder offers a natural, plant-based alternative to conventional cholesterol medications. Its additional benefits, such as digestive health support, make it an attractive choice.
    • The oat beta-glucan market is projected to grow significantly, reaching US$ 846.1 Million by 20321.

In summary, Nutrim’s Oat Beta Glucan stands out as a competitive product, providing both cholesterol management and overall wellness benefits. Ceapro’s commercial launch will be an important milestone, but Nutrim’s existing formulation positions it well in the market

Comment by prophetoffactz on Feb 24, 2024 8:28pm
Let's spike Nutrim with avenanthramide... Nutrim Oat Beta Glucan 30 Servings | Nutrim
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities